InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,408.75
(
1.26%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.86
(
-0.05%
)
Bitcoin
65,800.00
(
-1.03%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 3697

Saturday, 06/02/2007 5:18:05 AM

Saturday, June 02, 2007 5:18:05 AM

Post# of 19309
Inhaled Alpha-1 Antitrypsin - Kamada
In a conference I attended on May, David Tsur kamada's CEO said that they already know that the inhaled dose is about 25% of the injectable one. Given the limitation of plasma supply, these are good news.
If efficacy will work fine, they will try the inhaled delivery for other indications such as Cistic Fibrosis which suppose to be more profitable.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up